Cargando…
_version_ 1785062864143253504
author Nuber-Champier, A.
Cionca, A.
Breville, G.
Voruz, P.
Jacot de Alcântara, I.
Allali, G.
Lalive, P.H.
Benzakour, L.
Lövblad, K.-O.
Braillard, O.
Nehme, M.
Coen, M.
Serratrice, J.
Reny, J.-L.
Pugin, J.
Guessous, I.
Landis, B.N.
Griffa, A.
Van De Ville, D.
Assal, F.
Péron, J.A.
author_facet Nuber-Champier, A.
Cionca, A.
Breville, G.
Voruz, P.
Jacot de Alcântara, I.
Allali, G.
Lalive, P.H.
Benzakour, L.
Lövblad, K.-O.
Braillard, O.
Nehme, M.
Coen, M.
Serratrice, J.
Reny, J.-L.
Pugin, J.
Guessous, I.
Landis, B.N.
Griffa, A.
Van De Ville, D.
Assal, F.
Péron, J.A.
author_sort Nuber-Champier, A.
collection PubMed
description
format Online
Article
Text
id pubmed-10292659
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-102926592023-06-27 Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104] Nuber-Champier, A. Cionca, A. Breville, G. Voruz, P. Jacot de Alcântara, I. Allali, G. Lalive, P.H. Benzakour, L. Lövblad, K.-O. Braillard, O. Nehme, M. Coen, M. Serratrice, J. Reny, J.-L. Pugin, J. Guessous, I. Landis, B.N. Griffa, A. Van De Ville, D. Assal, F. Péron, J.A. Psychoneuroendocrinology Corrigendum The Author(s). Published by Elsevier Ltd. 2023-06-26 /pmc/articles/PMC10292659/ /pubmed/37380558 http://dx.doi.org/10.1016/j.psyneuen.2023.106324 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Nuber-Champier, A.
Cionca, A.
Breville, G.
Voruz, P.
Jacot de Alcântara, I.
Allali, G.
Lalive, P.H.
Benzakour, L.
Lövblad, K.-O.
Braillard, O.
Nehme, M.
Coen, M.
Serratrice, J.
Reny, J.-L.
Pugin, J.
Guessous, I.
Landis, B.N.
Griffa, A.
Van De Ville, D.
Assal, F.
Péron, J.A.
Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]
title Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]
title_full Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]
title_fullStr Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]
title_full_unstemmed Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]
title_short Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]
title_sort corrigendum to “acute tnfα levels predict cognitive impairment 6–9 months after covid-19 infection” [psychoneuroendocrinology 153 (2023) 106104]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292659/
https://www.ncbi.nlm.nih.gov/pubmed/37380558
http://dx.doi.org/10.1016/j.psyneuen.2023.106324
work_keys_str_mv AT nuberchampiera corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT cioncaa corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT brevilleg corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT voruzp corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT jacotdealcantarai corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT allalig corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT laliveph corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT benzakourl corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT lovbladko corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT braillardo corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT nehmem corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT coenm corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT serratricej corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT renyjl corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT puginj corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT guessousi corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT landisbn corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT griffaa corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT vandevilled corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT assalf corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104
AT peronja corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104